Activin-ActRIIa antagonists and uses for treating multiple myeloma
US8173601B2 · kind B2 · utility
32Cited by
29References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2008 |
| Grant date | May 8, 2012 |
| Priority date | — |
| Expiry date | Jul 30, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.